| 01.07 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025 |
| 01.07 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025 |
| 24.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025 |
| 24.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025 |
| 20.06 12:19 | dpa-AFX: GNW-News: Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors |
| 20.06 12:19 | dpa-AFX: GNW-News: Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors |
| 17.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025 |
| 17.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025 |
| 13.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025 |
| 13.06 18:00 | dpa-AFX: GNW-News: IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025 |
| 12.06 18:00 | dpa-AFX: GNW-News: Ipsen - May 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital |
| 12.06 18:00 | dpa-AFX: GNW-News: Ipsen - May 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital |
| 04.06 08:48 | dpa-AFX: *DEUTSCHE BANK RESEARCH REINITIATES IPSEN WITH 'BUY' - PRICE TARGET 122 EUR |
| 04.06 08:48 | dpa-AFX: *DEUTSCHE BANK RESEARCH NIMMT IPSEN MIT 'BUY' WIEDER AUF - ZIEL 122 EUR |
| 02.06 07:00 | dpa-AFX: GNW-News: Ipsen S.A. - Initiation of the share buy-back program |
| 02.06 07:00 | dpa-AFX: GNW-News: Ipsen S.A. - Initiation of the share buy-back program |
| 31.05 14:00 | dpa-AFX: GNW-News: Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma |
| 31.05 14:00 | dpa-AFX: GNW-News: Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma |
| 21.05 18:00 | dpa-AFX: GNW-News: Ipsen S.A. - Annual General Meeting held on 21 May 2025 |
| 21.05 18:00 | dpa-AFX: GNW-News: Ipsen S.A. - Annual General Meeting held on 21 May 2025 |
|
|
